Chemomab Therapeutics (CMMB) Receivables - Net (2017 - 2019)
Chemomab Therapeutics (CMMB) posted Receivables - Net of $408000.0 for Q4 2019, down 66.99% on a QoQ basis from $1.2 million in Q3 2019, and down 88.01% year-over-year from $3.4 million in Q4 2018.
Chemomab Therapeutics (CMMB) Receivables - Net (2017 - 2019) Analysis & Trends
Chemomab Therapeutics' Receivables - Net history runs 3 years deep, the most recent figure standing at $408000.0 for Q4 2019.
- Quarterly Receivables - Net fell 88.01% year-over-year to $408000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $408000.0 (down 88.01% YoY) and the FY2019 annual result came in at $408000.0, down 88.01% from the prior year.
- Receivables - Net was $408000.0 for Q4 2019 at Chemomab Therapeutics, down from $1.2 million in the prior quarter.
- Across five years, Receivables - Net topped out at $3.4 million in Q4 2018 and bottomed at $400000.0 in Q4 2017.
- A 3-year average of $1.3 million and a median of $885000.0 in 2019 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2018 — Receivables - Net jumped 750.75% — and 2019, when it plunged 88.01%.
- Chemomab Therapeutics' Receivables - Net stood at $400000.0 in 2017, then soared by 750.75% to $3.4 million in 2018, then plunged by 88.01% to $408000.0 in 2019.
- Business Quant data shows CMMB's Receivables - Net at $408000.0 in Q4 2019, $1.2 million in Q3 2019, and $885000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Chemomab Therapeutics | 124.14 Mn | 113.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 408,000.00 |
| Dec 31, 2019 | 408,000.00 |
| Sep 30, 2019 | 1.24 Mn |
| Sep 30, 2019 | 1.24 Mn |
| Jun 30, 2019 | 885,000.00 |
| Jun 30, 2019 | 885,000.00 |
| Dec 31, 2018 | 3.40 Mn |
| Dec 31, 2018 | 3.40 Mn |
| Dec 31, 2017 | 400,000.00 |
| Dec 31, 2017 | 400,000.00 |